Response to: Neprilysin inhibitor-angiotensin II receptor blocker combination (sacubitril/valsartan)

被引：2
|
作者：
Petramala, Luigi [1 ]
Letizia, Claudio [1 ]
机构：
[1] Sapienza Univ Rome, Policlin Umberto 1, Unit Secondary Arterial Hypertens, Dept Translat & Precis Med, Viale Policlin 155, I-00185 Rome, Italy
来源：
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY | 2020年 / 6卷 / 04期
关键词：
D O I：
10.1093/ehjcvp/pvaa035
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：252 / 252
页数：1
相关论文
共 50 条
  • [31] Angiotensin receptor blocker neprilysin inhibitors
    Usuda, Daisuke
    Higashikawa, Toshihiro
    Hotchi, Yuta
    Usami, Kenki
    Shimozawa, Shintaro
    Tokunaga, Shungo
    Osugi, Ippei
    Katou, Risa
    Ito, Sakurako
    Yoshizawa, Toshihiko
    Asako, Suguru
    Mishima, Kentaro
    Kondo, Akihiko
    Mizuno, Keiko
    Takami, Hiroki
    Komatsu, Takayuki
    Oba, Jiro
    Nomura, Tomohisa
    Sugita, Manabu
    WORLD JOURNAL OF CARDIOLOGY, 2021, 13 (08): : 325 - 339
  • [32] Angiotensin II type 1 receptor genotype and response to angiotensin II receptor blocker valsartan in early stage diabetic nephropathy
    Takei, Kako
    Kimura, Tomomi
    Miyazaki, Mitsuhiro
    Matsumoto, Ryuma
    muramatsu, Masaaki
    JOURNAL OF HYPERTENSION, 2006, 24 : 223 - 223
  • [33] An Efficient and Telescopic Process for Valsartan, an Angiotensin II Receptor Blocker
    Aalla, Sampath
    Gilla, Goverdhan
    Bojja, Yakambram
    Anumula, Raghupathi Reddy
    Vummenthala, Prabhakar Reddy
    Padi, Pratap Reddy
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2012, 16 (04) : 682 - 686
  • [34] Prevention of Progressive Worsening of Heart Failure Over Time With The Angiotensin-receptor Neprilysin Inhibitor Sacubitril/valsartan (lcz696)
    McMurray, John
    Jhund, Pardeep
    Gong, Jianjian
    Rouleau, Jean
    Lefkowitz, Martin
    Desai, Akshay
    Rizkala, Adel
    Shi, Victor
    Swedberg, Karl
    Zile, Michael
    Solomon, Scott
    Packer, Milton
    CIRCULATION, 2015, 132
  • [35] Disposition and metabolism of [14C] Sacubitril/Valsartan (formerly LCZ696) an angiotensin receptor neprilysin inhibitor, in healthy subjects
    Flarakos, Jimmy
    Du, Yancy
    Bedman, Timothy
    Al-Share, Qusai
    Jordaan, Pierre
    Chandra, Priya
    Albrecht, Diego
    Wang, Lai
    Gu, Helen
    Einolf, Heidi J.
    Huskey, Su-Er
    Mangold, James B.
    XENOBIOTICA, 2016, 46 (11) : 986 - 1000
  • [36] Who 'nose', is it the angiotensin receptor neprilysin inhibitor?: a case series of persistent nasal pruritus in heart failure patients receiving sacubitril/valsartan
    Gan, Jaclyn
    Rheault, Haunnah
    Wong, Yee Weng
    EUROPEAN HEART JOURNAL-CASE REPORTS, 2021, 5 (12)
  • [37] Real-world experience with angiotensin ii receptor blocker neprilysin inhibitor: reverse remodelling is the norm
    Ana Sofia Martinho, A.
    Almeida, J.
    Franco, F.
    Costa, S.
    Baptista, R.
    Robalo, M.
    Pinho, A.
    Goncalves, L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 207 - 207
  • [38] Intervention in the prescribing of the combination of an angiotensin converting enzyme inhibitor and an angiotensin-II receptor blocker
    Portilla, Alfredo
    Torres, Daniel
    Enrique Machado-Duque, Manuel
    Enrique Machado-Alba, Jorge
    ATENCION PRIMARIA, 2016, 48 (04): : 272 - 274
  • [39] COMPARISON OF RENAL DYSFUNCTION IN SYSTOLIC HEART FAILURE PATIENTS TREATED WITH SACUBITRIL-VALSARTAN OR ACE INHIBITOR/ANGIOTENSIN RECEPTOR BLOCKER
    Tan, Nicholas
    Deng, Yihong
    Yao, Xiaoxi
    Sangaralingham, LIndsey
    Shah, Nilay
    Rule, Andrew
    Burnett, John
    Dunlay, Shannon
    Sangaralingham, Jeson
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1023 - 1023
  • [40] Transition from angiotensin-converting enzyme inhibitor/angiotensin-II-receptor-blocker to sacubitril/valsartan in chronic heart failure patients: Initial experiences in clinical practice
    Hlavata, Katerina
    Hoskova, Lenka
    Franekova, Janka
    Jabor, Antonin
    Kautzner, Josef
    Melenovsky, Vojtech
    Benes, Jan
    COR ET VASA, 2018, 60 (03) : E209 - E214
12345